Literature DB >> 20221293

Calculating pulmonary-mode-lethality risk avoidance associated with radionuclide decorporation countermeasures related to a radiological terrorism incident.

Bobby R Scott1.   

Abstract

Planning for and managing radiological terrorism incidents that involve the release of radionuclides from a dirty bomb requires considering the potential lifesaving impact of protective radionuclide decorporation countermeasures (e.g., lung lavage). Lung lavage therapy could prevent deaths via the pulmonary mode (which involves radiation pneumonitis and fibrosis) by reducing the radiation dose to the lung from inhaled radionuclides. The risk avoidance (RAV) assessment framework introduced in a related paper is used to evaluate the pulmonary-lethality-mode RAV due to lung lavage and the associated risk avoidance proportion (RAP) for hypothetical inhalation-exposure scenarios. The lethality RAV is a measure (on a scale from 0 to 1) of the actual risk reduction associated with the applied protective countermeasures. The lethality RAP is the lethality RAV divided by the lethality risk when no protective countermeasures are employed and is a useful measure of the efficacy of the countermeasures applied. Examples of pulmonary-mode lethality RAV and RAP calculations are presented for hypothetical scenarios involving lung lavage to remove beta and/or gamma-emitting radionuclides that are inhaled in highly insoluble forms. The approach presented could be used to develop optimal schemes for applying lung lavage therapy following a terrorist incident involving a dirty bomb.

Entities:  

Keywords:  Risk; countermeasures; decorporation; lethality; radionuclide

Year:  2009        PMID: 20221293      PMCID: PMC2836159          DOI: 10.2203/dose-response.09-026.Scott

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  6 in total

1.  Calculating hematopoietic-mode-lethality risk avoidance associated with radionuclide decorporation countermeasures related to a radiological terrorism incident.

Authors:  Bobby R Scott
Journal:  Dose Response       Date:  2009-10-08       Impact factor: 2.658

2.  Lung lavage therapy to lessen the biological effects of inhaled 144Ce in dogs.

Authors:  B A Muggenburg; B B Boecker; F F Hahn; R O McClellan
Journal:  Radiat Res       Date:  1990-11       Impact factor: 2.841

3.  A model for hematopoietic death in man from irradiation of bone marrow during radioimmunotherapy.

Authors:  B R Scott; L E Dillehay
Journal:  Br J Radiol       Date:  1990-11       Impact factor: 3.039

4.  Risk estimates for deterministic health effects of inhaled weapons grade plutonium.

Authors:  Bobby R Scott; Vern L Peterson
Journal:  Health Phys       Date:  2003-09       Impact factor: 1.316

5.  Health risk evaluations for ingestion exposure of humans to polonium-210.

Authors:  Bobby R Scott
Journal:  Dose Response       Date:  2007-04-20       Impact factor: 2.658

6.  The medical management of unintentional radionuclide intakes.

Authors:  B D Breitenstein
Journal:  Radiat Prot Dosimetry       Date:  2003       Impact factor: 0.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.